Like this bit:
A recent study used the technology to conjugate recombinant Spike RBD of selected SARS-CoV-2 variants. It sought to understand the impact of COVID-19 vaccination on the levels of neutralizing antibodies against these RBD variants, and demonstrated thatthe nanosized molecular glue approach to bioconjugation provides a rapid and effective tool for SARS-CoV-2 multiplex immunoassay development for vaccine study (1).
Like this bit: A recent study used the technology to conjugate...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
-0.001(4.55%) |
Mkt cap ! $51.83M | |||
| Open | High | Low | Value | Volume |
| 2.3¢ | 2.3¢ | 2.1¢ | $258.6K | 11.65M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 7214585 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 799070 | 4 |
View Market Depth
| Last trade - 14.40pm 30/07/2024 (20 minute delay) ? |
| ADO (ASX) Chart |